MedPath

Effect of a lidocaine patch in the reduction of the lower limb amputation pain.

Phase 1
Conditions
ower limb amputation pain: phantom limb pain and primary/secondary scar hyperalgesia.
Therapeutic area: Body processes [G] - Bones and nerves physological processes [G11]
Registration Number
EUCTR2016-000864-41-BE
Lead Sponsor
Centre Hospitalier Universitaire Brugmann
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
20
Inclusion Criteria

All above or below knee amputations in the first two months after surgery, after complete wound healing (no clips, no stitches, no seepage)
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 5
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 15

Exclusion Criteria

- individuals younger than 18 years old
- patients with history of central nervous system disease
- patients with history of major psychiatric disease (MMS<23/30, HADS <8/21)
- pregnancy
- known hypersensitivity to local anesthetics (lidocaine, bupivacaine, etidocaine, mepivacaine, prilocaine)
- skin irritation of the stump

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath